One postdoctoral researcher position is available immediately to study pathobiology of breast cancer. The projects will be supported by US Department of Defense (Breast Cancer Program, 2015-2018). My laboratory has a major focus on the cancer genome (microRNA alterations: PNAS 2006 and PNAS 2008; lncRNA alterations: Cancer Cell 2014), host-tumor interaction (Nature Cell Biol. 2009 and Cancer Research 2010), as well as cancer biological therapy (New Eng. J. Med. 2003 and Nature 2011) of breast and ovarian cancers.
The project will focus on DNA damage, epigenetic regulation and breast tumorigenesis. CRISPR/Cas9 and next generation sequencing technologies will be used in this project. The position requires experience in cellular and molecular biology, such as the experimental technology on molecular mechanisms that control malignant transformation, tumor progression and metastasis. Previous experience in knock-out and transgenic animals, RNA biology, epigenetics, cancer biology and cancer genomics would be helpful. We are also welcome the candidates, who are trained in other fields such as prostate cancer and melanoma biology, developmental biology, genetics and genomics, to apply these positions.
The candidate for postdoc must have a Ph.D. degree and have less than 3 years postdoctoral experience in a related field. Candidates are expected to work independently, be highly creative and self-motivated. Please forward a cover letter, an updated c.v. including a list of your publications, and the addresses of 3 references to:
Lin Zhang MD Associate Professor
Institute for Translational Medicine and Therapeutics
University of Pennsylvania School of Medicine
Tel: 215-573-4780 (office)
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 17 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $392 million awarded in the 2013 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania — recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital — the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2013, Penn Medicine provided $814 million to benefit our community. …